Copyright
©The Author(s) 2015.
World J Gastroenterol. Dec 7, 2015; 21(45): 12767-12777
Published online Dec 7, 2015. doi: 10.3748/wjg.v21.i45.12767
Published online Dec 7, 2015. doi: 10.3748/wjg.v21.i45.12767
Figure 2 Intravital fluorescent lymphangiography 30 min after oral gavage administration of Bodipy-FL-C16.
Lymphangiography showing mesenteric lymphatic drainage in control (A, n = 4) and mice with dextran sulfate sodium (DSS)-induced colitis (B, n = 5) after oral gavage of 1 mL of Bodipy-FL-C16. Significantly reduced number of fluorescent mesenteric lymphatic vessels was observed in mice with DSS-induced colitis as compared to control mice (E). Scale bar = 2 mm. IHC assessment of lymphatic vessels using antibody against LYVE-1 in the colon of control (C) and mice with DSS-induced colitis (D) and quantification of number of lymphatic vessels (F) and vessel area (G) in colons. Data presented as mean ± SE. aP < 0.05 control vs DSS day 7.
- Citation: Agollah GD, Wu G, Peng HL, Kwon S. Dextran sulfate sodium-induced acute colitis impairs dermal lymphatic function in mice. World J Gastroenterol 2015; 21(45): 12767-12777
- URL: https://www.wjgnet.com/1007-9327/full/v21/i45/12767.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i45.12767